Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies
BackgroundAdoptive T-cell and natural killer (NK)-cell therapies are expanding across solid tumors, but their registered development in gynecologic malignancies remains difficult to interpret because many studies use basket designs and registry records…